CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 184 enrolled
Drug / intervention
Ergoferon +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01850446
NCT01850446Phase 4Completed
CompareCT.gov

Comparative Parallel-group Randomized Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Materia Medica Holding·interventional·Posted May 9, 2013·Updated Apr 16, 2020

In Brief

A Phase 4 clinical trial evaluating Ergoferon and Oseltamivir for Influenza. Completed, enrolled 184 participants across 7 sites.

Detailed Summary

The purpose of this study is: * to assess the efficacy of Ergoferon in treatment of influenza; * to assess the safety of Ergoferon in treatment of influenza; * to compare the efficacy of Ergoferon and Oseltamivir for treatment of influenza.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesRussia
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 9, 2013
Enrollment StartFeb 20, 2015
Primary CompletionApr 16, 2018
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 13.1 years ago

Interventions

Ergoferondrug

Safety and Efficacy

Oseltamivirdrug

Safety and Efficacy